Birmingham biotech company receives $1.2M toward research

A Birmingham biotech company has received over a million dollars in funding toward research to treat a chronic kidney disease.

Source: bizjournals.com Health Care:Physician Practices headlines - June 16, 2022 Category: American Health Authors: Laurel Thrailkill Source Type: news